Life Sciences | Monitoring the Pulse of the Life Sciences Industry
Blogs

Life Sciences

Monitoring the Pulse of the Life Sciences Industry

Key Takeaways Re: CX And Your Relationships With Clinical Sites

In the previous five posts in this series, I’ve taken you on a little journey designed to help you improve your relationship with your clinical sites, thereby boosting their performance and reducing your costs. In this, the final post in the series, I’ll summarize the key takeaways and offer up some additional resources to help […]

Read more

Alleviate Payment Pains For Clinical Sites And Investigators

Imagine with me: An investigator running a site in one of your studies logs in to see an overview of his payment history. Something seems off, so he begins to review each payment in detail, and comes across what he believes to be the source of the problem – the withholding for his first payment […]

Read more

CX Methodology And Site Relationships: Duke-FDA Case Study

If you haven’t read the previous posts in this series, be forewarned that this week’s post might be a little hard to follow, as it assumes you have all of the context from the series to-date. Still, I encourage you to dive in, and I’ll do my best to connect all of the dots for […]

Read more

Consider This When Migrating To Argus Safety

When I’m approached by clients to discuss safety projects, it is generally about implementing Oracle’s Argus Safety, upgrading the system, or discussing their ability to comply with regulatory requirements. Recently, I was asked about migrating from a legacy drug safety database to Argus. We discussed the methods available, such as leveraging an Oracle dump, a […]

Read more

CX Insights And Journey Maps Improve Clinical Site Relationships

In the previous posts in this series, I’ve explained why you should consider clinical sites as your “customers,” and what customer experience (CX) methodology is and how it’s used. In this post, I’ll explain how the methodology applies to clinical sites and how the insights it provides can help improve site relationships. With the notion […]

Read more

What Exactly Is CX Methodology (And Why Should I Care)?

In the previous posts in this series on improving relationships with clinical sites, I discussed why it’s beneficial to think of your clinical sites as your customers so that you can use customer experience (CX) methodology to improve those relationships. In this post, I’ll explain what CX methodology is and why it matters. At its […]

Read more

Why You Need To Think Of Clinical Sites As Your Customers

Earlier this year, Duke University and the United States Food and Drug Administration (FDA) published a jointly conducted study focused on principal investigator (PI) retention. After surveying 201 PIs, they confirmed the industry’s suspicion that PI turnover is a serious issue: 54.2% of respondents reported that they completed a single clinical trial and then stopped. […]

Read more

Critical Components Of The Preclinical Stage Of FDA Drug Approval

Last time, I published a post that posed the question: why are prescription drugs in the U.S. so expensive? Today’s post is the first in a brief series that will attempt to provide an answer by looking each stage of the FDA drug approval process, starting with preclinical. Below are the key components of the […]

Read more

What Exactly Is An “Adverse Drug Reaction?”

While there are many ways to define “adverse drug reaction,” let’s use one that is fairly simply to digest: an unintended, harmful response that is suspected to be caused by a medicinal product being taken under normal circumstances. According to some sources, adverse drug reactions are the sixth-leading cause of death in the United States, […]

Read more

How To Determine The Risk Level Of A Regulated IT System

In the previous post in this series, I discussed the process you can use to determine whether a particular IT system is regulated. That post described the first part of a four-part approach to assessing and mitigating risk with regulated IT systems. Today’s post will cover the second part – what to do once you […]

Read more

Perficient Life Sciences

We monitor the pulse of the life sciences industry, from clinical to digital. Read about the trends, insights, successes, warnings, and solutions that move science forward.

Archives